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Protozoan parasites are remarkably sensitive to dinitroanilines such as oryzalin, which disrupt plant but not animal
microtubules. To explore the basis of dinitroaniline action, we isolated 49 independent resistant Toxoplasma gondii lines
after chemical mutagenesis. All 23 of the lines that we examined harbored single point mutations in ␣-tubulin. These
point mutations were sufficient to confer resistance when transfected into wild-type parasites. Several mutations were in
the M or N loops, which coordinate protofilament interactions in the microtubule, but most of the mutations were in the
core of ␣-tubulin. Docking studies predict that oryzalin binds with an average affinity of 23 nM to a site located beneath
the N loop of Toxoplasma ␣-tubulin. This binding site included residues that were mutated in several resistant lines.
Moreover, parallel analysis of Bos taurus ␣-tubulin indicated that oryzalin did not interact with this site and had a
significantly decreased, nonspecific affinity for vertebrate ␣-tubulin. We propose that the dinitroanilines act through a
novel mechanism, by disrupting M-N loop contacts. These compounds also represent the first class of drugs that act on
␣-tubulin function.

INTRODUCTION
Microtubules are polymers constructed from ␣-␤-tubulin
heterodimers (Downing and Nogales, 1998a,b). These structures are rapidly assembled and disassembled to create essential components of eukaryotic cells, such as spindles and
flagella. The dynamic nature of microtubules makes them
susceptible to pharmacological agents. Microtubule-disrupting and microtubule-stabilizing drugs have provided great
insight into tubulin and microtubule function; they also
have tremendous practical use. Compounds that perturb
microtubule dynamics are currently some of the most effective drugs to treat medical conditions, including cancer,
gout, and helminth infection (Jordan et al., 1998). Dinitroanilines (oryzalin, ethafluralin, and trifluralin) disrupt the
microtubules of plants, ranging from the single-celled alga
Chlamydomonas reinhardtii to higher plants such as the monocot Eleusine indica (James et al., 1993; Anthony et al., 1998;
Zeng and Baird, 1999). Dinitroanilines also disrupt the microtubules of protozoa, including both free-living species
such as Tetrahymena and protozoan parasites such as
Trypanosoma spp., Leishmania spp., Entamoeba spp., Plasmodium falciparum, Cryptosporidium parvum, and Toxoplasma
gondii (Chan and Fong, 1990; Chan et al., 1991; Gu et al., 1995;
Edlind et al., 1996; Stokkermans et al., 1996; Armson et al.,
1999; Makioka et al., 2000a,b; Traub-Cseko et al., 2001). Remarkably, the activity of dinitroanilines is restricted to
plants and protozoa; these compounds are ineffective
against vertebrate or fungal microtubules (Chan and Fong,
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1990; Hugdahl and Morejohn, 1993; Murthy et al., 1994;
Edlind et al., 1996).
T. gondii is a member of the Apicomplexa, a phylum of
parasites that includes several medically and agriculturally
significant pathogens (Black and Boothroyd, 2000). Apicomplexans are obligate intracellular parasites; these protozoa
only grow and replicate within host cells. Extracellular parasites released by host cell lysis must rapidly invade new
host cells to stay alive. Despite these rigorous requirements
for parasite survival, apicomplexans are some of the most
widespread and damaging pathogens. Human infection by
T. gondii can cause life-threatening illness in immunocompromised individuals and birth defects or miscarriage during fetal infection (Hill and Dubey, 2002). Other apicomplexans include Plasmodium and Cryptosporidium, parasites of
considerable medical importance, and Theileria and Eimeria,
animal pathogens with extensive impact on food production
(Levene, 1988).
Parasites of the Apicomplexa are named for their distinctly polarized cell apex that contains a number of unique
organelles that coordinate invasion of host cells. Apicomplexan parasites are surrounded by the pellicle, a composite
structure formed by association of the plasma membrane
with the inner membrane complex, an assemblage of flattened vesicles (Porchet and Torpier, 1977; Dubremetz and
Torpier, 1978). There are two populations of microtubules in
the invasive stages of apicomplexan parasites: subpellicular
microtubules and spindle microtubules (Morrissette and
Sibley, 2002a,b). Subpellicular microtubules are nondynamic; they maintain both apical polarity and the characteristic crescent shape of the parasite by interacting with the
pellicle (Morrissette et al., 1997). Spindle microtubules form
an intranuclear spindle to coordinate chromosome segregation. Both populations are critically important to parasite
survival and replication. Although extracellular parasites
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are refractory to the effects of microtubule-disrupting drugs,
during intracellular growth parasite microtubules are dynamic and are highly sensitive to disruption (Stokkermans et
al., 1996).
In this work, we demonstrate that Toxoplasma resistance to
oryzalin is associated with point mutations to ␣-tubulin. The
point mutations are sufficient to confer oryzalin resistance
when introduced into wild-type (sensitive) parasites. When
mapped onto the structure of ␣-tubulin, most mutations
cluster in the core of the protein. Using representative structures of Toxoplasma ␣-tubulin taken from a molecular dynamics trajectory, we find that oryzalin consistently docks to
␣-tubulin and binding is altered in several point mutants
due to conformational changes. When a similar analysis is
carried out on vertebrate ␣-tubulin, oryzalin has significantly lower affinity and does not bind to the same region.
MATERIALS AND METHODS
Mutagenesis and Selection of Oryzalin-resistant Lines
Toxoplasma tachyzoites (RH strain) were propagated in human foreskin fibroblast (HFF) cells in DMEM with 10% fetal bovine serum. Approximately 107
extracellular tachyzoites were mutagenized in 50 or 100 g/ml N-nitroso-Nethylurea (Sigma-Aldrich, St. Louis, MO) in serum-free minimal essential
medium for 1 h at 37°C. The parasites were washed and inoculated into 20
T25 flasks containing HFF cells. All subpopulations were kept independent to
prevent isolation of sibling lines. Oryzalin (Riedel-deHaen, Seelze, Germany)
stock solutions were made up in dimethyl sulfoxide. Parasites were selected
at either 0.5 or 2.5 M oryzalin. Oryzalin-resistant parasites were single cell
cloned in 96-well dishes of HFF cells (Roos et al., 1994).

Drug Assays
Toxoplasma has two discrete populations of microtubules: spindle microtubules and subpellicular microtubules. The characteristic elongated shape of
Toxoplasma is maintained by the ⬃6-m-long subpellicular microtubules.
Shortening these subpellicular microtubules with oryzalin converts parasites
to a distinctive round shape. Parasites with shortened microtubules can
continue to replicate until they lyse from a host cell. However, round parasites are incapable of invading new host cells and die (Morrissette and Sibley,
2002b). To assess oryzalin resistance in the individual lines, we scored parasite shape and subpellicular microtubule length in increasing concentrations
of oryzalin. Parasites were grown overnight in HFF cells on coverslips in
increasing concentrations of oryzalin. The coverslips were processed for
immunofluorescence staining with a rabbit peptide antibody that specifically
recognizes Toxoplasma ␤-tubulin (Morrissette and Sibley, 2002b). Parasites
were scored as having 1) a wild-type or “elongated” phenotype in which the
subpellicular microtubules are long and parasites have an elongated shape, or
having 2) a “round” phenotype in which the parasites are noninvasive because the subpellicular microtubules are shortened making parasites round
(Morrissette and Sibley, 2002b). Resistance to oryzalin was scored as the
highest concentration of drug in which intracellular replicating parasites
maintained an elongated shape and long subpellicular microtubules. Because
long subpellicular microtubules impart parasites with the capacity to reinvade host cells, these microtubules are an indicator of the ability to proliferate
in oryzalin.

Amplification of the ␣-Tubulin Genes from the Oryzalinresistant Lines
Genomic DNA was isolated from resistant Toxoplasma lines. The ␣-tubulin
gene was amplified from genomic DNA by using PFU turbo (Stratagene, La
Jolla, CA) in an MJ research thermocycler with 30 cycles of annealing at 45°C
for 30 s followed by 5 min of extension at 68°C. The primers GAGTCTCGTAGAGAAC AAGC (5⬘ untranslated region [UTR]) and CGTTTATACCTTCACCTTTTC (3⬘ UTR) amplified a 2.3-kb fragment of ␣-tubulin. Amplified
sequences were purified (polymerase chain reaction purification kit; QIAGEN, Valencia, CA), quantified on a 1% agarose gel and sequenced.

Sequencing the ␣-Tubulin Genes from the Oryzalinresistant Lines
The following primers were used to obtain sequence from ␣-tubulin by using
the Big Dye II sequencing reaction (ABI, Foster City, CA). 5⬘ UTR:
GAGTCTCGTAGAGAACAAGC; 3⬘ UTR: CGTTTATACCTTCACCTTTTC; 3⬘
exon 1: GCTACGCGGGAGATC; 5⬘ exon 2: GGTTACAGCGGAACTACG; 3⬘
exon 2: CGGTTCCCACAGTCATATC; 5⬘ exon 3: GCGTCAAATCTGCAAC;
forward exon 3a: CCGTCCTTTCCACTCAC; reverse exon 3a: GTGAGTGGAAAGGACGG; forward exon 3b: GTACCGTGGTGATGTCGTC; reverse
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exon 3b: GACGACATCACCACGGTAC. Sequences were aligned and compared using the Sequencher program (Genecodes, Ann Arbor, MI).

Introduction of Novel Restriction Site
The QuikChange kit (Stratagene) was used to ablate a unique XbaI site in the
second intron of ␣-tubulin and to introduce a novel BamH1 site by using the
primers BamH1 RE site sense GTATCACCTCTTCCACCGGGATCCTATGACTGTGGGAACCG and BamH1 RE site antisense CGGTTCCCACAGTCATAGGATCCCGGTGGAAGAGGTGATAC. This alteration distinguishes
the endogenous tubulin gene from the transgene to discriminate Toxoplasma
transformants with allelic replacement from those with nonhomologous insertions.

Creation of ␣-Tubulin Point Mutations
The mutations Ser165Pro, Ser165Thr, Ser165Ala, Ile231Thr, and Thr239Ile
were constructed using the QuikChange kit (Stratagene) to modify the sequence of wild-type genomic ␣-tubulin containing the BamH1 restriction site.
The Ser165Pro construct was created with primers Ser165Pro sense GTTGACTACGGCAAGAAGCCGAAGCTGAACTTCTGC and Ser165Pro antisense
GCAGAAGTTCAGCTTCGGCTTCTTGCCGTAGTCAAC. The Ser165Thr
construct was created with primers Ser165Thr sense GTTGACTACGGCAAGAAGACGAAGCTGAACTTCTGCTCG and Ser165Thr antisense CGAGCAGAAGTTCAGCTTCGTCTTCTTGCCGTAGTCAAC. The Ser165Ala construct
was created with primers Ser165Ala sense GTTGACTACGGCAAGAAGGCGAAGCTGAACTTCTGCTCG and Ser165Ala antisense CGAGCAGAAGTTCAGCTTCGCCTTCTTGCCGTAGTCAAC. The Ile231Thr construct was created with primers Ile231Thr sense GACTGATTGCCCAGGTCACCTCCTCCCTGACC and Ile231Thr antisense GGTCAGGGAGGAGGTGACCTGGGCAATCAGTC. The Thr239Ile construct was created with the primers
Thr239Ile sense GCCCAGGTCATCTCCTCCCTGATCGCGTCTCTCCG and
Thr239Ile antisense CGGAGAGACGCGATCAGGGAGGAGATGACCTGGGC. Double and triple mutant constructs were created using the same
primers to sequentially introduce the individual point mutations. Because the
Ile231Thr and the Thr239Ile primers overlap, the primers GACTGATTGCCCAGGTCACCTCCTCCCTGATC and GATCAGGGAGGAGGTGACCTGGGCAATCAGTC were used to introduce the Thr239Ile mutation into the
Ile231Thr construct.

Transformation, Selection, and Analysis of Oryzalinresistant Transformants
The linearized transgene constructs with the diagnostic restriction enzyme
change and the point mutation were electroporated into RH strain
tachyzoites. Approximately 107 tachyzoites were transfected with ⬃8 g of
DNA by using electroporation parameters established previously (Soldati and
Boothroyd, 1993). Parasites were selected in 0.5 M oryzalin; resistant
tachyzoites were single cell cloned (as described above). Individual clones
were assayed for transformation by amplification of the ␣-tubulin gene by
using the primers 5⬘ coding CAAAATGAGAGAGGTTATCAGC and 3⬘ coding TTAGTACTCGTCACCATAGCC. Amplified ␣-tubulin was digested with
either XbaI or BamH1. Transformed parasites (allelic replacements and
pseudodiploids) were assayed for their drug resistance by using increasing
concentrations of oryzalin (see above).

Tubulin Structure Analysis
The amino acid sequences of Sus scrofa (pig) (gi:15988311) and T. gondii
(gi:161937) ␣-tubulins were aligned using Clustal within the Vector NTI suite
of programs (Higgins et al., 1996). The amino acid sequences of Toxoplasma
␣-tubulin (gi:161937) was fit to the structure of bovine tubulin (1JFF) by using
the Swiss-Model Automated Comparative Protein Modeling Server (http://
www.expasy.ch/swissmod/) in the first approach mode (Guex and Peitsch,
1997). The resulting structure was viewed with SwissPdb Viewer version 3.7
(http://www.expasy.ch/spdbv/).

Computational Techniques
To prepare ␣-tubulin for our docking studies, the missing residues (Gln35 to
Lys60) of bovine ␣-tubulin were modeled based on the analogous bovine
␤-tubulin N loop structure (1JFF). This homology modeling was followed by
energy minimization using the OPLSAA force-field in Tinker 4.1 (http://
dasher.wustl.edu/ponder; Ponder and Richards, 1987). We created the T.
gondii ␣-tubulin structure by mutating the completed bovine structure to the
Toxoplasma ␣-tubulin sequence by using WHAT-IF (Vriend, 1990). The coordinates of the N-site GTP (1JFF) were obtained from the Protein Data Bank.
The resulting complexes (Toxoplasma ␣-tubulin with GTP and bovine ␣-tubulin with GTP) were minimized, heated and equilibrated using NAMD, a
package developed by the Theoretical and Computational Biophysics Group
in the Beckman Institute for Advanced Sciences and Technology at the University of Illinois at Urbana-Champaign (Kale et al., 1999). Molecular dynamics simulations were performed using the CHARMM27 force-field with TIP3P
solvent. Representative structures were taken every 500 ps from the 2.5-ns
trajectory for use in the docking simulations. By using AutoDock3.0 (Morris
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Figure 1. Left, levels of resistance to oryzalin displayed by the Toxoplasma lines selected
in 0.5 M oryzalin (horizontal gray line).
Most lines selected for resistance to 0.5 M
oryzalin showed only slight resistance to increased oryzalin. Right, Toxoplasma lines selected in 2.5 M oryzalin (horizontal gray
line). Most lines selected for resistance to 2.5
M oryzalin were highly resistant to increased oryzalin.

et al., 1998), flexible docking of oryzalin onto each snapshot taken from the
trajectory were performed. Thirty trial runs were carried out for each ␣-tubulin conformation followed by cluster analysis of the results.

RESULTS
Oryzalin-resistant Tachyzoites Have Diverse Phenotypes
Although dinitroanilines are potent inhibitors of microtubules in plants and protozoa, their precise mode of action is
unknown. To determine the molecular basis of dinitroaniline action, we generated oryzalin-resistant lines by using
the chemical mutagen N-nitroso-N-ethylurea (Waldeland et
al., 1983; Pfefferkorn, 1984; Dobrowolski and Sibley, 1996).
Because Toxoplasma is haploid, genetic changes that confer
resistance are readily detected, including mutations that are
recessive in diploid organisms. We selected for resistance to
either 0.5 or 2.5 M oryzalin. In earlier work, we demonstrated that parasites treated with 0.5 M oryzalin have
shortened, nonfunctional subpellicular microtubules but intact spindle microtubules. In contrast, parasites treated with
2.5 M oryzalin are missing all microtubules (Morrissette
and Sibley, 2002b). The individual oryzalin-resistant Toxoplasma lines displayed distinct drug resistance profiles (Figure
1 and Table 1). Most of the 0.5 M resistant lines were only
moderately resistant to increased oryzalin concentrations. In
contrast, the majority of the 2.5 M resistant lines were resistant to ⬎10-fold increases in oryzalin concentration.
The Oryzalin-resistant Lines Harbor Different Single ␣Tubulin Point Mutations
One potential mechanism for resistance to the dinitroanilines would be mutations to tubulin that alter drug binding or
microtubule dynamics. The single ␣-tubulin gene from 23 of
the 49 oryzalin-resistant lines was amplified and sequenced
to identify base changes conferring amino acid substitutions
to tubulin. Each line had a single point mutation to ␣-tubulin; collectively, there were 21 different amino acid substitutions at 16 positions in ␣-tubulin (Table 1). Ser165 was a
particularly frequent target and was mutated in five of the
23 lines to threonine, proline, or alanine. Either isoleucine or
leucine replaced Phe52 and either cysteine or serine replaced
Arg243. The Thr239Ile point mutation was also previously
identified in E. indica (goosegrass) as a dinitroaniline-resistant ␣-tubulin mutation (Anthony et al., 1998).
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Tubulin Mutations Are Sufficient to Confer Oryzalin
Resistance in Toxoplasma
To demonstrate that the ␣-tubulin mutations were sufficient
to confer oryzalin resistance in a wild-type background, they
were introduced into the parental Toxoplasma strain. To distinguish wild-type ␣-tubulin from the ␣-tubulin transgene,
intron 2 was altered to ablate a unique XbaI restriction site
and to introduce a unique BamHI restriction site (Figure 2A).
The BamHI restriction site is closely linked to the individual
point mutations. Five single point mutations (Ser165Pro,
Ser165Thr, Ser165Ala, Ile231Thr, and Thr239Ile) were individually introduced into this construct. To test whether the
substitutions were additive in combination, the double and
triple permutations of these substitutions were also made.
A linear construct of the ␣-tubulin gene containing the
BamHI restriction site and the specific point mutation or
mutations was transfected into wild-type (sensitive) Toxoplasma. After 24 h of recovery, the parasites were placed
under selection in 0.5 M oryzalin, the lowest concentration
of drug that effectively selects for resistance. Resistant parasites were single cell cloned and expanded. The lines were
assayed for allelic integration versus random insertion of the
transgene by amplification of the ␣-tubulin gene from parasite lysate and restriction enzyme analysis of the product
(Figure 2B). As a control, the wild-type ␣-tubulin gene with
the restriction site change was transfected into Toxoplasma;
resistant lines did not arise after selection in 0.5 M oryzalin.
Transformation of the tubulin point mutation genes was
sufficient to confer resistance to oryzalin in Toxoplasma (Figure 3). In the pseudodiploid (nonhomologous integration)
state (Figure 3, black bars), point mutations conferred resistance to lower levels of oryzalin than did allelic replacements of the same constructs (Figure 3, white bars). Allelic
replacement of wild-type tubulin with the ␣-tubulin point
mutations conferred resistance to between 0.75 and 5.0 M
oryzalin. The single point mutation Thr239Ile conferred the
highest level of resistance. In almost all cases, the double and
triple point mutation combinations were less resistant than
the single mutations, indicating that these point mutations
were not additive in combination (Figure 3, panels 2 and 3).
However, the double mutation Ser165Ala/Thr239Ile was
highly resistant to oryzalin (⬎90 M; Figure 3, panel 4),
indicating that these substitutions are synergetic. Oryzalin is
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Table 1. Properties of the oryzalin-resistant lines
Amino acid
substitution

Oryzalin selection

His8Tyr
His28Gln
Phe52Ile
Phe52Leu
Leu136Phe
Asn139Lys
Ser165Ala
Ser165Pro
Ser165Pro
Ser165Thr
Ser165Thr
Ile231Thr
Ile235Val
Leu238Val
Thr239Ile
Arg243Cys
Arg243Ser
Val252Leu
Ile275Thr
Ala295Val
Met301Thr
Ile378Met
Met391Ile
Tyr24His
Thr239Ile
Met268Thr

0.5 M
0.5 M
0.5 M
2.5 M
2.5 M
0.5 M
2.5 M
0.5 M
0.5 M
0.5 M
0.5 M
0.5 M
0.5 M
0.5 M
2.5 M
2.5 M
2.5 M
0.5 M
0.5 M
0.5 M
0.5 M
0.5 M
0.5 M
C. reinhardtii a
E. indicta b
E. indicta b

a
b

Maximum
resistance, M

Codon change

Location in protein

10.0
1.0
2.5
2.5
⬎25
1.0
5.0
1.0
5.0
2.0
⬎25
1.0
1.0
1.0
⬎25
⬎25
⬎25
⬎25
0.5
2.0
⬎25
3.0
1.0

CAC to TAC
CAT to CAA
TTC to ATC
TTC to CTC
TTG to TTC
AAC to AAA
TCG to GCG
TCG to CCG
TCG to CCG
TCG to ACG
TCG to ACG
ATC to ACC
ATC to GTC
CTG to GTG
ACC to ATC
CGT to AGT
CGT to TGT
GTG to TTG
ATC to ACC
GCT to GTT
ATG to ACG
ATC to ATG
ATG to ATT

␤-sheet 1
N loop
N loop
N loop
(␤-sheet 4)
␤-sheet 4
␤-sheet 5
␤-sheet 5
␤-sheet 5
␤-sheet 5
␤-sheet 5
␣-helix 7
␣-helix 7
␣-helix 7
␣-helix 7
After ␣-helix 7
After ␣-helix 7
(␣-helix 8)
M loop
Near M loop (␣-helix 9)
After ␣-helix 9
␤-sheet 10
␣-helix 11
Near N loop
(␣-helix 7)
Near M loop

From James et al. (1993).
From Yamamoto et al. (1998).

insoluble in aqueous solutions above ⬃95 M, making it
impossible to determine the full degree of drug resistance of
the Ser165Ala/Thr239Ile double mutation.
In some cases, two of the resistant lines from the mutagenesis screen contained the same ␣-tubulin point mutation but

displayed distinct resistance profiles. The clearest example
of this was seen with the Ser165Thr point mutation. Two
lines harbored this substitution but showed dramatically
different resistance profiles: one line was resistant to 2.0 M
oryzalin, whereas the other was resistant to ⬎25 M oryza-

Figure 2. (A) Diagram of the exon-intron structure of ␣-tubulin. Endogenous (wild-type) ␣-tubulin has a unique XbaI restriction site in
intron 2. The transgene was altered to ablate the XbaI site and to introduce a unique BamHI site in intron 2. The point mutations Ser165Pro,
Ser165Thr, Ser165Ala, Ile231Thr, and Thr239Ile were introduced in the transgene construct both individually and in double and triple
combinations. The ␣-tubulin from transformants with oryzalin resistance was amplified with primers (arrows) that are internal to the 5⬘ and
3⬘ ends of the transgene and represent the 5⬘ end of exon 1 and 3⬘ end of exon 3. (B) Restriction enzyme analysis of the transformed
oryzalin-resistant lines gives easily distinguishable patterns after amplification of the ␣-tubulin gene. The endogenous (WT) ␣-tubulin gene
is cut by BamH1 and is not cut by XbaI. Conversely, the allelic replacement (AR, homologous integration) is cut by XbaI and is not cut by
BamHI. Nonhomologous integration of the transgene creates a pseudodiploid (PD). In this case, both the BamHI and XbaI enzymes cut
incompletely.
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Figure 3. Degree of oryzalin resistance was assessed for lines transformed with the ␣-tubulin constructs. The resistance of both homologous
integrations (allelic replacements) and nonhomologous integrations (pseudodiploids) was measured for each construct. Allelic replacements
(white bars) show greater oryzalin resistance than do pseudodiploids (black bars). Panel 1, single mutations (1) Ser165Pro, (2) Ser165Thr, (3)
Ser165Ala, (4) Ile231Thr, and (5) Thr239Ile. Panel 2, double mutations (6) Ser165Pro/Ile231Thr, (7) Ser165Pro/Thr239Ile,
(8) Ser165Thr/Ile231Thr, (9) Ser165Thr/Thr239Ile, (10) Ser165Ala/Ile231Thr, (11) Ser165Ala/Thr239Ile, and (12) Ile231Thr/Thr239Ile. Panel
3, triple mutations (13) Ser165Pro/Ile231Thr/Thr239Ile, (14) Ser165Thr/Ile231Thr/Thr239Ile, and (15) Ser165Ala/Ile231Thr/Thr239Ile.
Allelic replacements of Ser165Pro/Ile231Thr and Ser165Ala/Ile231Thr/Thr239Ile were not obtained nor were nonhomologous integrations
of Ser165Ala and Ser165Pro/Ile231Thr. Panel 4, synergism of the double point mutation Ser165Ala/Thr239Ile. (3) Ser165Ala, (5) Thr239Ile,
and (11) Ser165Ala/Thr239Ile lines.

lin (Table 1). When the Ser165Thr point mutation was introduced as an allelic replacement, the ␣-tubulin point mutation alone conferred resistance to 2.0 M oryzalin (Figure 3).
Therefore, the line with resistance to ⬎25 M oryzalin must
have an additional mutation(s) superimposed upon the
␣-tubulin mutation to increase resistance to oryzalin. We
hypothesize that lines with high levels of drug resistance
(Figure 1) have additional mutations superimposed on the
␣-tubulin mutation to increase resistance to oryzalin.
Most Tubulin Mutations Localize to the Core of ␣Tubulin
The 23 point mutations identified in this study were distributed throughout the linear sequence of Toxoplasma ␣-tubulin. To investigate how these amino acid mutations might
affect tubulin function, we evaluated their conservation in
other ␣-tubulins and their spatial distribution in a structural
model of ␣-tubulin. Figure 4A is a Clustal alignment of S.
scrofa ␣-tubulin (insensitive to the dinitroanilines) with Toxoplasma ␣-tubulin. Although some point mutations occur in
residues that distinguish Toxoplasma (sensitive) from pig
(insensitive) ␣-tubulin, many resistance mutations occur in
conserved amino acids. The amino acid sequence of Toxoplasma ␣-tubulin was fit to the electron diffraction structure
of bovine ␣-tubulin by using the Swiss-Model Automated
Comparative Protein Modeling Server Web site in the first
approach mode. The mutated amino acids in ␣-tubulin were
identified within the modeled Toxoplasma ␣-tubulin structure. Two previously identified plant mutations Tyr24His
and Met268Thr that confer dinitroaniline resistance were
also included in our analysis (James et al., 1993; Yamamoto et
al., 1998). The majority of the point mutations clustered
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within the core of ␣-tubulin (Figure 4B). Some of the mutated residues were distributed in striking patterns. For
example, several of the mutated resides residues (Ile231,
Ile235, and Thr239) localized along a single face of helix 7 in
␣-tubulin (Figure 4C). Arg243 and Leu238 were also in this
immediate proximity. In addition, His8, Leu136, and Ser165
occupied essentially linear positions on three strands (␤strands 1, 4, and 5) of a ␤-sheet (Figure 4C, inset).
Some Mutations Localize to Domains That Coordinate
Protofilament-Protofilament Contact
Structural studies have established the critically important
role of two tubulin domains (the M loop and the N loop) in
microtubule assembly. These loops coordinate lateral interactions between protofilaments to build a microtubule. Studies docking the tubulin dimer structure into high-resolution
images of microtubules have established that M loops interact with N loops of laterally adjacent subunits (Li et al.,
2002). Moreover, organisms with increased microtubule stability (such as arctic fish) have two amino acid substitutions
in the ␣-tubulin M loop, Ala278Thr and Ser287Thr (Detrich
et al., 2000). The oryzalin-resistant point mutation Ile275Thr
was an M loop substitution, and three of the point mutations
described here (His28Gln, Phe52Ile, and Phe52Leu) were in
the N loop (Figure 4). These ␣-tubulin mutations may compensate for the destabilizing effects of the dinitroanilines by
increasing the intrinsic stability of Toxoplasma microtubules.
Identification of the Oryzalin Binding Site
Although our analysis of the resistance mutations implies
that oryzalin binds to ␣-tubulin, the spatial distribution of
the mutations and the fact that many mutations were in the
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Figure 4. (A) Clustal alignment of oryzalin-sensitive Toxoplasma (Tg) and oryzalin-insensitive pig (S. scrofa, Ss) ␣-tubulins. A yellow
background represents amino acid identity, teal denotes residue similarity, and white indicates nonconserved residues. The distribution of
␣-helices, ␤-strands, and coils in bovine ␣-tubulin (black, below Clustal sequence) were adapted from Lowe et al. (2001) who solved the
structure of bovine tubulin, but mapped it onto the amino acid sequence of pig tubulin. The three red lines (H1, H3⬘, and B5) indicate regions
where the predicted secondary structure of Toxoplasma ␣-tubulin deviates from the bovine secondary structure. The boxed residues are
mutated in the individual oryzalin-resistant lines. The blue-labeled residues were identified in Toxoplasma oryzalin-resistant lines in this
study. Three dinitroaniline resistance mutations (two labeled in green and one with a green asterisk) were identified in previous work in
Chlamydomonas and Eleusine. (B and C) The amino acid sequence of Toxoplasma ␣-tubulin was fit to the structure of bovine ␣-tubulin by using
Swiss-Model automated comparative protein modeling. B shows a ribbon model of Toxoplasma ␣-tubulin (white). The residues that are
mutated to confer oryzalin resistance are colored red. The plant mutations at residues 24 and 268 are colored green. The position of the N
loop containing the Phe52 mutations is not necessarily accurate because this area was disordered in structural studies and was eliminated
from the final model. C shows cut-away views of some of the ␣-tubulin residues that are mutated to confer oryzalin resistance. Many residues
are in striking proximity and show specific orientations. For example, residues Ile231, Ile235, and Thr239 all occur on the same face of ␣-helix
7. Leu238, Arg243, and Val252 cluster in the same general area. The inset shows a ␤-sheet formed by ␤-strands 1, 4, and 5. The mutated
residues His8, Leu136, and Ser165 are in a linear pattern across the ␤-sheet.
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Figure 5. (A) Representative structure of oryzalin bound to ␣-tubulin as predicted by the docking simulations. The binding site consists of
Arg2, Glu3, Val4, Trp21, Phe24, His28, Ile42, Asp47, Arg64, Cys65, Thr239, Arg243, and Phe244. Residues Phe24, His28, Thr239, and Arg243
(yellow) were mutated in resistant lines; all other binding site residues are colored green. The binding site lies beneath the N loop (translucent
red). The SO2 group of oryzalin forms a hydrogen bond with the backbone amide (NH) of Arg64 (red). (B) Two protofilaments, each consisting
of two ␣-␤ heterodimers, with bound oryzalin (blue). Oryzalin binds to ␣-tubulin (silver) beneath the N loop (red); this may interfere with lateral
interactions between the N loop and the M loop (yellow) of the adjacent protofilament. The inset shows oryzalin bound beneath the N loop.

core of the protein suggested that the mutations did not
directly define a binding site for the dinitroanilines. For this
reason, we used computational techniques, with molecular
dynamics simulations to generate multiple conformations
for Toxoplasma ␣-tubulin, and flexible docking simulations to
locate the binding site (see MATERIALS AND METHODS).
The representative structures of Toxoplasma ␣-tubulin taken
from this molecular dynamics trajectory, showed that oryzalin consistently docked to residues Arg2, Glu3, Val4, Trp21,
Phe24, His28, Ile42, Asp47, Arg64, Cys65, Thr239, Arg243,
and Phe244 (Figure 5A). The binding affinity at this site was
23 nM. This binding site placed oryzalin beneath the N loop
(Figure 5). We also analyzed Toxoplasma ␣-tubulin containing point mutations that conferred resistance. For the mutants Thr239Ile, Ser165Ala, and Thr239Ile/Ser165Ala, oryzalin binding was eliminated at the site identified in the wildtype Toxoplasma ␣-tubulin.
In parallel studies, we investigated the interaction of
oryzalin with Bos taurus ␣-tubulin by docking oryzalin to a
set of structures obtained from the molecular dynamics trajectories. The results indicated that oryzalin does not interact
with equivalent residues in vertebrate ␣-tubulin. It has a
significantly decreased overall affinity (⬎50-fold) for bovine
tubulin and no true consensus binding site. The limited
interaction of oryzalin with bovine tubulin does not imply a
secondary binding site for oryzalin on bovine ␣-tubulin but
indicates nonspecific, low-affinity interactions in single tubulin snapshots.
DISCUSSION
Analysis of oryzalin resistance in T. gondii implicates ␣-tubulin as the target for dinitroaniline action. We demonstrate
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here that all Toxoplasma lines with resistance to oryzalin have
a point mutation in the single ␣-tubulin gene. These ␣-tubulin point mutations are sufficient to confer resistance to
oryzalin in Toxoplasma. The preponderance of ␣-tubulin mutations identified in this study suggests that dinitroanilines
bind to and act on ␣-tubulin. This is unusual, as all characterized compounds that perturb microtubule function bind
to and act on ␤-tubulin (Nogales, 2000). Several of the resistance mutations are located in the M or N loops, regions of
tubulin that mediate lateral adhesion of protofilaments
(Downing and Nogales, 1998a; Nogales et al., 1998, 1999;
Lowe et al., 2001). These mutations are predicted to counteract dinitroaniline action by hyperstabilizing microtubules.
However, most mutations were found to be in the core of
␣-tubulin. We hypothesize that core mutations affect the
conformation of the ␣-tubulin dinitroaniline binding site.
Docking simulations were used to identify the ␣-tubulin
binding site for oryzalin. These simulations were based on a
genetic algorithm where the results of individual searches
are clustered based on their root mean square deviation. For
each ␣-tubulin conformation, we found the consensus binding site (Figure 5A) was both the largest cluster and contained the binding conformations with the highest affinity.
The binding affinity predicted for this site was 23 nM and is
in agreement with experimentally determined values of 95–
117 nM obtained with purified plant tubulin (Hugdahl and
Morejohn, 1993; Murthy et al., 1994). The site identified by
our docking simulations is located beneath the N loop and is
composed of residues Arg2, Glu3, Val4, Trp21, Phe24, His28,
Ile42, Asp47, Arg64, Cys65, Thr239, Arg243, and Phe244
(Figure 5A). Several resistance mutations (Phe24, His28,
Thr239, and Arg243) map to this binding site. We propose
that additional mutated residues in the core of ␣-tubulin also
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affect dinitroaniline binding at this site. For example, Thr239
is a binding site residue located on ␣-helix 7 along with
mutated residues Ile231, Ile235, and Leu238 (Figures 4C and
5A). Presumably, mutation of any one of these other amino
acids alters ␣-helix 7, the behavior of Thr239, and ultimately
the properties of the binding site (conformation, flexibility,
and dynamics). In a recent article, Blume et al. (2003) used
analysis of surface electrostatic potential to suggest that
dinitroanilines bind ␣-tubulin residues located at the dimer
interface. They propose a binding site consisting of Cys4,
His8, Leu136, Phe138, Thr239, Arg243, Asp251, Val252, and
Asn253 based on a region of altered electrostatic potential
between wild-type E. indica ␣-tubulin and the resistant ␣-tubulin Thr239Ile point mutation. Although their predicted
binding site is in the same vicinity and shares three common
residues (Val/Cys4, Thr239, and Arg243), the two predictions are distinct. Our binding site is not at the dimer-dimer
interface, but rather directly behind the N-loop, suggesting a
direct mechanism for affecting lateral contacts that lead to
microtubule disruption (see below).
The selective action of the dinitroanilines on plant and
protozoan tubulin suggests that only plant and protozoan
␣-tubulins bind these compounds. This is supported by our
computational analysis docking oryzalin to a set of B. taurus
␣-tubulin structures obtained from molecular dynamics trajectories. Oryzalin has a decreased overall affinity for bovine
tubulin and the trajectory snapshots do not contain a consistent oryzalin binding site. Plant and protozoan lineagerestricted residues do not directly account for the lack of a
consensus binding site because binding site residues are not
specific to plants and protozoa. We hypothesize that lineage
restricted residues elsewhere in ␣-tubulin selectively create a
binding pocket in plant and protozoan ␣-tubulin (Morrissette, Mitra, and Sept, unpublished data).
Beyond allowing us to identify the binding site on ␣-tubulin, our docking results suggest a mechanism for how
dinitroanilines cause microtubule disassembly. When oryzalin was inserted into the ␣-tubulin binding site within the
microtubule structure, it was situated beneath the N loop
between protofilaments in the microtubule (Figure 5B).
Studies fitting the tubulin dimer structure into high-resolution cryoelectron microscopy images of microtubules have
established that protofilament-protofilament contact is mediated by N loops interacting with M loops of laterally
adjacent subunits (Li et al., 2002). Oryzalin bound beneath
the N loop may inhibit N loop interaction with the M loop of
the adjacent protofilament (Figure 5B, enlargement) with the
consequence of microtubule disruption. Indeed, the significance of M-N loop contact for microtubule stability can be
appreciated by considering the action of taxol, a drug which
stabilizes microtubules by reinforcing M-N loop interactions
in ␤-tubulin (Snyder et al., 2001).
Dinitroaniline resistance was previously investigated in
the single cell alga Chlamydomonas reinhardtii. Resistance in
Chlamydomonas is rarely due to mutations to tubulin (James
et al., 1988; James and Lefebvre, 1989; James et al., 1989, 1993;
Lux and Dutcher, 1991; Schibler and Huang, 1991). Instead,
some resistance alleles act as a multidrug resistance pump
(James and Lefebvre, 1989), whereas others are regulators of
tubulin polymerization. Although Chlamydomonas is haploid, it has two copies of both the ␣- and ␤-tubulin genes
(Silflow and Rosenbaum, 1981). Presumably, tubulin-based
resistance does not arise in Chlamydomonas because these
mutations are masked by expression of the other wild-type
tubulin gene. The ␤-tubulin mutations Lys350Met and
Lys350Glu confer hypersensitivity to the microtubule-stabilizing drug taxol and resistance to dinitroanilines and other
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microtubule-disrupting drugs such as colchicine. These
mutations function by hyperstabilizing microtubules and
are not dinitroaniline specific (Schibler and Huang, 1991).
The ␣-tubulin mutation Tyr24His was identified as a
“step-up” mutation in a Chlamydomonas strain with low
levels of dinitroaniline resistance and is the only specific
dinitroaniline-resistance allele associated with tubulin
(James et al., 1993).
The weed goosegrass rapidly acquires resistance to dinitroaniline herbicides (Anthony et al., 1998, 1999; Yamamoto
et al., 1998; Anthony and Hussey, 1999; Zeng and Baird,
1999). These studies demonstrated that the ␣-tubulin mutations Thr239Ile and Met268Thr were associated with resistance to dinitroanilines and that the double point mutation
(not observed in the original lines) produced higher oryzalin
resistance than either of the single mutations alone. Multiple
␣- and ␤-tubulin genes are characteristic of higher plants
and animals; this property complicated analysis of tubulin
mutations in oryzalin-resistant goosegrass. To confer oryzalin resistance with ␣-tubulin transgenes, the ␣-tubulin point
mutations had to be overexpressed by driving both ␣- and
␤-tubulin transgene expression with the powerful cauliflower mosaic virus 35S/maize alcohol dehydrogenase intron 1 hybrid promoter (Anthony et al., 1999). In contrast to
goosegrass, Toxoplasma is haploid and has single ␣- and
␤-tubulin genes (Nagel and Boothroyd, 1988). It is therefore
ideally suited for genetic analysis of recessive mutations that
would be masked in a diploid organism, particularly one
with redundant gene family members. These genetic qualities allowed the isolation of a large number of tubulin mutations that are partially recessive to wild-type tubulin.
It is well established that dinitroanilines selectively inhibit
the microtubules of plants and protozoa and do not act on
fungal or vertebrate tubulins (Chan and Fong, 1990; Chan et
al., 1991; James et al., 1993; Gu et al., 1995; Edlind et al., 1996;
Stokkermans et al., 1996; Anthony et al., 1998, 1999; Anthony
and Hussey, 1999; Armson et al., 1999; Zeng and Baird, 1999;
Makioka et al., 2000a,b; Traub-Cseko et al., 2001). Dinitroaniline disruption of plant microtubules has been exploited to
develop these compounds as components of a variety of
preemergence herbicides. The selective disruption of protozoan parasite microtubules by the dinitroanilines indicates
that tubulin is a suitable chemotherapeutic target for control of
parasite infection. Understanding the nature of the interaction
between dinitroanilines and protozoan tubulin is key to the
development of novel antiparasitic drugs with selective activity, appropriate pharmacokinetic properties, and low human
toxicity. Moreover, studies on the mechanism of dinitroaniline
disruption of microtubules will increase our understanding of
the role of ␣-tubulin in microtubule polymerization.
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